The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
In vivo drug discovery in the zebrafish
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effective targeted gene ‘knockdown’ in zebrafish
Nasevicius, A., & Ekker, S. C. (2000) · Nature Genetics · doi:10.1038/79951 · Cited by 2,483
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
Heart Regeneration in Zebrafish
Poss, K. D., Wilson, L. G., & Keating, M. T. (2002) · Science · doi:10.1126/science.1077857 · Cited by 1,932
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Self-citationHaffter, P., Granato, M., Brand, M., Mullins, M. C., Hammerschmidt, M., Kane, D. A., Odenthal, J., J. M. van Eeden, F., Jiang, Y.-J., Heisenberg, C.-P., et al. (1996) · Development · doi:10.1242/dev.123.1.1 · Cited by 1,662
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
A genetic screen for mutations affecting embryogenesis in zebrafish
Driever, W., Solnica-Krezel, L., Schier, A. F., Neuhauss, S. C. F., Malicki, J., Stemple, D. L., Stainier, D. Y. R., Zwartkruis, F., Abdelilah, S., Rangini, Z., et al. (1996) · Development · doi:10.1242/dev.123.1.37 · Cited by 1,337
Hit and lead generation: beyond high-throughput screening
Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1086 · Cited by 1,056
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family
Yi Li, Q., Newbury-Ecob, R. A., Terrett, J. A., Wilson, D. I., Curtis, A. R. J., Ho Yi, C., Gebuhr, T., Bullen, P. J., Robson, S. C., Strachan, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0197-21 · Cited by 927
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
Tobert, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1112 · Cited by 875
Cited by
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish
Egan, R. J., Bergner, C. L., Hart, P. C., Cachat, J. M., Canavello, P. R., Elegante, M. F., Elkhayat, S. I., Bartels, B. K., Tien, A. K., Tien, D. H., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.022 · Cited by 1,376
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Lee, K. J., Nallathamby, P. D., Browning, L. M., Osgood, C. J., & Xu, X.-H. N. (2007) · ACS Nano · doi:10.1021/nn700048y · Cited by 724
Seyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Measuring behavioral and endocrine responses to novelty stress in adult zebrafish
Cachat, J., Stewart, A., Grossman, L., Gaikwad, S., Kadri, F., Chung, K. M., Wu, N., Wong, K., Roy, S., Suciu, C., et al. (2010) · Nature Protocols · doi:10.1038/nprot.2010.140 · Cited by 695
Strähle, U., Scholz, S., Geisler, R., Greiner, P., Hollert, H., Rastegar, S., Schumacher, A., Selderslaghs, I., Weiss, C., Witters, H., et al. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.06.121 · Cited by 673
Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos
Bar‐Ilan, O., Albrecht, R. M., Fako, V. E., & Furgeson, D. Y. (2009) · Small · doi:10.1002/smll.200801716 · Cited by 648
The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish
Hall, C., Flores, M. V., Storm, T., Crosier, K., & Crosier, P. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-42 · Cited by 591
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
Target profiling of small molecules by chemical proteomics
Rix, U., & Superti-Furga, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.216 · Cited by 575
Use of Zebrafish in Drug Discovery Toxicology
Cassar, S., Adatto, I., Freeman, J. L., Gamse, J. T., Iturria, I., Lawrence, C., Muriana, A., Peterson, R. T., Van Cruchten, S., & Zon, L. I. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00335 · Cited by 561
Self-citationResolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish
Mathias, J. R., Perrin, B. J., Liu, T.-X., Kanki, J., Look, A. T., & Huttenlocher, A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506346 · Cited by 537
Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish
Prober, D. A., Rihel, J., Onah, A. A., Sung, R.-J., & Schier, A. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4332-06.2006 · Cited by 508
Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol
MacPhail, R. C., Brooks, J., Hunter, D. L., Padnos, B., Irons, T. D., & Padilla, S. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2008.09.011 · Cited by 474
Zebrafish: An Emerging Model System for Human Disease and Drug Discovery
Kari, G., Rodeck, U., & Dicker, A. P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100223 · Cited by 467
Analyzing habituation responses to novelty in zebrafish (Danio rerio)
Wong, K., Elegante, M., Bartels, B., Elkhayat, S., Tien, D., Roy, S., Goodspeed, J., Suciu, C., Tan, J., Grimes, C., et al. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.023 · Cited by 463
The resolution of inflammation: Principles and challenges
Headland, S. E., & Norling, L. V. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.014 · Cited by 410
Xia, T., Zhao, Y., Sager, T., George, S., Pokhrel, S., Li, N., Schoenfeld, D., Meng, H., Lin, S., Wang, X., et al. (2011) · ACS Nano · doi:10.1021/nn1028482 · Cited by 379
Orlova, V. V., van den Hil, F. E., Petrus-Reurer, S., Drabsch, Y., ten Dijke, P., & Mummery, C. L. (2014) · Nature Protocols · doi:10.1038/nprot.2014.102 · Cited by 365
Hao, J., Ho, J. N., Lewis, J. A., Karim, K. A., Daniels, R. N., Gentry, P. R., Hopkins, C. R., Lindsley, C. W., & Hong, C. C. (2010) · ACS Chemical Biology · doi:10.1021/cb9002865 · Cited by 365
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
Elemental and Chemically Specific X-ray Fluorescence Imaging of Biological Systems
Pushie, M. J., Pickering, I. J., Korbas, M., Hackett, M. J., & George, G. N. (2014) · Chemical Reviews · doi:10.1021/cr4007297 · Cited by 332
Development of a zebrafish embryo teratogenicity assay and quantitative prediction model
Brannen, K. C., Panzica‐Kelly, J. M., Danberry, T. L., & Augustine‐Rauch, K. A. (2010) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20223 · Cited by 328
High-throughput in vivo vertebrate screening
Pardo-Martin, C., Chang, T.-Y., Koo, B. K., Gilleland, C. L., Wasserman, S. C., & Yanik, M. F. (2010) · Nature Methods · doi:10.1038/nmeth.1481 · Cited by 325
High-resolution imaging of the dynamic tumor cell–vascular interface in transparent zebrafish
Stoletov, K., Montel, V., Lester, R. D., Gonias, S. L., & Klemke, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703446104 · Cited by 325
Immunology and zebrafish: Spawning new models of human disease
Meeker, N. D., & Trede, N. S. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2007.11.011 · Cited by 311
Zebrafish: Model for the Study of Inflammation and the Innate Immune Response to Infectious Diseases
Novoa, B., & Figueras, A. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0106-3_15 · Cited by 293
Gebauer, D. L., Pagnussat, N., Piato, Â. L., Schaefer, I. C., Bonan, C. D., & Lara, D. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.021 · Cited by 289
Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption
Segner, H. (2009) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cbpc.2008.10.099 · Cited by 287
The future of drug safety testing: expanding the view and narrowing the focus
Stevens, J. L., & Baker, T. K. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.11.009 · Cited by 286
Zebrafish embryos as models for embryotoxic and teratological effects of chemicals
Yang, L., Ho, N. Y., Alshut, R., Legradi, J., Weiss, C., Reischl, M., Mikut, R., Liebel, U., Müller, F., & Strähle, U. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.04.013 · Cited by 283
Zebrafish: A Complete Animal Model for In Vivo Drug Discovery and Development
Chakraborty, C., Hsu, C., Wen, Z., Lin, C., & Agoramoorthy, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787522197 · Cited by 279
A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation
Paquet, D., Bhat, R., Sydow, A., Mandelkow, E.-M., Berg, S., Hellberg, S., Fälting, J., Distel, M., Köster, R. W., Schmid, B., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37537 · Cited by 278
Barros, T. P., Alderton, W. K., Reynolds, H. M., Roach, A. G., & Berghmans, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.249 · Cited by 275
Berghmans, S., Hunt, J., Roach, A., & Goldsmith, P. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.03.015 · Cited by 266
Chen, X., Wang, Y., Ma, N., Tian, J., Shao, Y., Zhu, B., Wong, Y. K., Liang, Z., Zou, C., & Wang, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0186-y · Cited by 263
Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity
Fako, V. E., & Furgeson, D. Y. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.008 · Cited by 261
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
Molina, G., Vogt, A., Bakan, A., Dai, W., de Oliveira, P. Q., Znosko, W., Smithgall, T. E., Bahar, I., Lazo, J. S., Day, B. W., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.190 · Cited by 259
Zebrafish embryos and larvae: A new generation of disease models and drug screens
Ali, S., Champagne, D. L., Spaink, H. P., & Richardson, M. K. (2011) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20206 · Cited by 257
Nanocosmetics and Nanomedicines
(2011) · doi:10.1007/978-3-642-19792-5 · Cited by 116
Premature aging in telomerase-deficient zebrafish
Anchelin, M., Alcaraz-Pérez, F., Martínez, C. M., Bernabé-García, M., Mulero, V., & Cayuela, M. L. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011635 · Cited by 114
Sanjeewa, K. K. A., Jayawardena, T. U., Kim, S.-Y., Kim, H.-S., Ahn, G., Kim, J., & Jeon, Y.-J. (2019) · Algal Research · doi:10.1016/j.algal.2019.101561 · Cited by 76
Quick, R. E., Buck, L. D., Parab, S., Tolbert, Z. R., & Matsuoka, R. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.735598 · Cited by 32
Hematopoietic stem cells, hematopoiesis and disease: lessons from the zebrafish model
Martin, C. S., Moriyama, A., & Zon, L. I. (2011) · Genome Medicine · doi:10.1186/gm299 · Cited by 29
“Chemical genetics studies have investigated a variety of pathways, and large-scale chemical screens have identified many small molecules displaying clinical promise [4-6].”
BackgroundSelf-citationA Simple, Highly Visual in Vivo Screen for Anaplastic Lymphoma Kinase Inhibitors
Rodrigues, F. S. L. M., Yang, X., Nikaido, M., Liu, Q., & Kelsh, R. N. (2012) · ACS Chemical Biology · doi:10.1021/cb300361a · Cited by 15
Probing PAC1 receptor activation across species with an engineered sensor
Cola, R. B., Niethammer, S. N., Rajamannar, P., Gresch, A., Bhat, M. A., Assoumou, K., Williams, E. T., Hauck, P., Hartrampf, N., Benke, D., et al. (2024) · eLife · doi:10.7554/elife.96496 · Cited by 4
The small molecule ML233 is a direct inhibitor of tyrosinase function
Menard, R., Baanannou, A., Halluin, C., Morse, D., Kuhn, S., Graber, J. H., Strickland, J., & Madelaine, R. (2025) · Communications Biology · doi:10.1038/s42003-025-07973-5 · Cited by 2
Katona, G., Jovanovic Ljeskovic, N., Strahinic, I., Stanisavljevic, N., Vojvodic, S., Djuris, J., & Pavic, A. (2025) · Molecules · doi:10.3390/molecules30204134 · Cited by 1
“The optical transparency of zebrafish embryos enables simultaneous, real-time, multiparametric evaluation of systemic toxicity and direct visualization of treatment effects on skin melanocyte pigmentation and integrity [51].”
Probing PAC1 receptor activation across species with an engineered sensor
(2024) · doi:10.1101/2024.02.06.579048
Metadata
- Authors
- Zon, L. I., & Peterson, R. T.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-01-01
- Volume
- 4
- Issue
- 1
- Pages
- 35-44
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2009766076
- Cited by
- 1,353
- References
- 71
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.